EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
60 Degrees Pharmaceuticals Inc. (SXTP) had EBIT Margin of -521.27% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.31M |
|
$-1.73M |
|
$0.05M |
|
$0.26M |
|
$1.91M |
|
$-1.60M |
|
$-0.13M |
|
$-1.73M |
|
$-1.73M |
|
$-1.73M |
|
$-1.73M |
|
$-1.73M |
|
$-1.73M |
|
$-1.60M |
|
$-1.54M |
|
1.47M |
|
1.47M |
|
$-1.25 |
|
$-1.25 |
|
| Balance Sheet Financials | |
$3.84M |
|
$0.19M |
|
$0.34M |
|
$4.18M |
|
$1.69M |
|
-- |
|
$0.15M |
|
$1.84M |
|
$-7.22M |
|
$2.20M |
|
$2.35M |
|
1.47M |
|
| Cash Flow Statement Financials | |
$-3.05M |
|
$1.65M |
|
$1.70M |
|
$1.66M |
|
$1.97M |
|
$0.31M |
|
$0.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.27 |
|
-- |
|
-- |
|
-- |
|
-- |
|
83.74% |
|
-521.27% |
|
|
EBIT Margin |
-521.27% |
-- |
|
-563.04% |
|
-563.13% |
|
$-3.10M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
0.06 |
|
1.04 |
|
86.25 |
|
24.02% |
|
-78.79% |
|
-41.49% |
|
-73.96% |
|
$1.59 |
|
$-2.11 |
|
$-2.07 |
|